Lund:Publications: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(New page: <!--Possible lab page template. To use simply copy the following text into you lab page and then replace each instance of LabName with your own lab's name--> {{Template:Lund}} <div style=...) |
No edit summary |
||
| Line 3: | Line 3: | ||
<div style="padding: 10px; width: 720px; border: 5px solid #000000;"> | <div style="padding: 10px; width: 720px; border: 5px solid #000000;"> | ||
::''' | |||
'''2013''' | |||
*Hirosue S., Vokali E., Raghavan V., Rincon-Restrepo M., Lund AW., Capotosti F., Courthesy-Henrioud P., Halin-Winter C., Hugues S., Swartz MA. Steady-state antigen scavenging, cross-presentation and CD8+ T cell priming: a new role for lymphatic endothelial cells. ''In review''. | |||
*Thomas SN., Vokali E., Lund AW., Hubbell JA., Swartz MA. Targeting the tumor-draining lymph node with adjuvanted nano particles reshapes the anti-tumor immune response. ''Biomaterials''. accepted September 2013. | |||
*Kilarski W.W., Guc E., Teo JC., Oliver SR., Lund AW., Swartz MA. Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis. ''PLoS One''. 2013;8(2):e57135. [http://www.ncbi.nlm.nih.gov/pubmed/23451163] | |||
*Lund AW., Duraes FV., Hirosue S., Raghavan VR., Nembrini C., Thomas SN., Issa A., Hugues S., Swartz MA. VEGF-C promotes immune tolerance in B16 melanoma and cross-presentation of tumor antigen by lymph node lymphatics. ''Cell Rep''. 2012 Mar 29;1(3):191-9. [http://www.ncbi.nlm.nih.gov/pubmed/22832193] | |||
'''2012''' | |||
'''2010''' | |||
'''2009''' | |||
'''2008''' | |||
'''2005''' | |||
</div> | </div> | ||
[[Category:Lab]] | [[Category:Lab]] | ||
Revision as of 13:20, 14 October 2013
2013
- Hirosue S., Vokali E., Raghavan V., Rincon-Restrepo M., Lund AW., Capotosti F., Courthesy-Henrioud P., Halin-Winter C., Hugues S., Swartz MA. Steady-state antigen scavenging, cross-presentation and CD8+ T cell priming: a new role for lymphatic endothelial cells. In review.
- Thomas SN., Vokali E., Lund AW., Hubbell JA., Swartz MA. Targeting the tumor-draining lymph node with adjuvanted nano particles reshapes the anti-tumor immune response. Biomaterials. accepted September 2013.
- Kilarski W.W., Guc E., Teo JC., Oliver SR., Lund AW., Swartz MA. Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis. PLoS One. 2013;8(2):e57135. [1]
- Lund AW., Duraes FV., Hirosue S., Raghavan VR., Nembrini C., Thomas SN., Issa A., Hugues S., Swartz MA. VEGF-C promotes immune tolerance in B16 melanoma and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 2012 Mar 29;1(3):191-9. [2]
2012
2010
2009
2008
2005
